Impact of Type 1 Diabetes Technology on Family Members/Significant Others of People With Diabetes
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: The aim was to explore the impact of diabetes-related technology to ensure that such devices are used in a way that returns maximum benefit from a medical and psychological perspective. Method: Spouses and caregivers of people with type 1 diabetes were invited to complete an online questionnaire about their experiences with diabetes technologies used by their family members. Participants were recruited via the Glu online community website. Questions explored impact on daily living, frequency and severity of hypoglycemia, and diabetes-related distress. Results: In all, 100 parents/caregivers and 74 partners participated in this survey. Average (mean) duration of living with a person with type 1 diabetes was 16 years (SD = 13) for partners, with duration of diabetes for children being 4.2 ± 3.2 years. Average duration of current therapy was 8.3 ± 7.3 years for adults and 3.4 ± 2.9 years for children. Of the participants, 86% partners and 82% parents/caregivers reported diabetes technology had made it easier for their family members to achieve blood glucose targets. Compared to partners, parents/caregivers reported more negative emotions ( P < .001) and decreased well-being ( P < .001) related to their family members type 1 diabetes. Diabetes-related distress was common, as was sleep disturbance associated with device alarms and fear of hypoglycemia. Reduced frequency and severity of hypoglycemia related to device use was reported by approximately half of participants. Conclusion: There is little doubt about the medical benefit of diabetes technologies and their uptake is increasing but some downsides were reported. Barriers to uptake of technologies lie beyond the mechanics of diabetes management. Supporting users in using diabetes technology to achieve the best possible glycemic control, in the context of their own life, is crucial. Furthermore, understanding these issues with input from the type 1 diabetes community including family members and caregivers will help innovation and design of new technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ly, T. T., Nicholas, J. A., Retterath, A., Lim, E. M., Davis, E. A., & Jones, T. W. (2013) · JAMA · doi:10.1001/jama.2013.277818 · Cited by 411 · cited 1×
“A reported benefit of insulin pump therapy, CGM, and artificial pancreas use is reduced severity and frequency of hypoglycemia.(7,8) This outcome was reported by half of participants, who believed their family member experienced fewer hypoglycemic events, and similarly half reported reduced severity of hypoglycemic ev…”
BackgroundValidation of the WHO-5 Well-Being Index in Adolescents With Type 1 Diabetes
de Wit, M., Pouwer, F., Gemke, R. J. B. J., Delemarre-van de Waal, H. A., & Snoek, F. J. (2007) · Diabetes Care · doi:10.2337/dc07-0447 · Cited by 335
Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry
Wong, J. C., Foster, N. C., Maahs, D. M., Raghinaru, D., Bergenstal, R. M., Ahmann, A. J., Peters, A. L., Bode, B. W., Aleppo, G., Hirsch, I. B., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0303 · Cited by 318 · cited 1×
“Discontinuation rates are high, however, at 41% of users having discontinued use by 1 year.(5) Currently, there is limited research on the impact of diabetes technologies on the lives of those people who live with someone with T1D and their role in helping them to support that person.”
Background
Cited by
Sleep in type 1 diabetes: implications for glycemic control and diabetes management
Perez, K. M., Hamburger, E. R., Lyttle, M., Williams, R., Bergner, E., Kahanda, S., Cobry, E., & Jaser, S. S. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0974-8 · Cited by 86
Nefs, G. M., Bazelmans, E., Donga, E., Tack, C. J., & de Galan, B. E. (2020) · Diabetic Medicine · doi:10.1111/dme.14211 · Cited by 30
Giza, S., Kotanidou, E. P., Tsinopoulou, V. R., Poukoulidou, T., Ntouma, S., & Galli-Tsinopoulou, A. (2025) · Children · doi:10.3390/children12121668 · Cited by 7
“Studies recorded the impact of alarm fatigue among patients [18,29,31,33,34,36,43– 45,47 ,49 ,53 , 55 ], their parents [22 ,27 ,32,35,38,42,46, The main reasons responsible for alarm fatigue concerned either everyday life [22,25,29,31,33,34,37,39,41,43,45,46,49,51,52] or sleep [18,25,27,29,31–38,…”
Metadata
- Authors
- Barnard, K., Crabtree, V., Adolfsson, P., Davies, M., Kerr, D., Kraus, A., Gianferante, D., Bevilacqua, E., & Serbedzija, G.
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2016-04-25
- Volume
- 10
- Issue
- 4
- Pages
- 824-830
- ISSN
- 1932-2968 (ISSN-L)
- OpenAlex
- W2343543601
- Cited by
- 61
- References
- 3
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of Type 1 Diabetes Technology on Family Members/Significant Others of People With Diabetes. https://app.cochat.ai/papers/10.1177/1932296816645365
- The paper
- Barnard, K., Crabtree, V., Adolfsson, P., Davies, M., Kerr, D., Kraus, A., Gianferante, D., Bevilacqua, E., & Serbedzija, G. (2016). Impact of Type 1 Diabetes Technology on Family Members/Significant Others of People With Diabetes. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296816645365
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.